KHADRA MOHAMED: Open Payments
NPI 1558052324 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,844 in 172 payments from 21 companies in 2025. Trend: 2023 $263 · 2024 $2,901 · 2025 $3,844
Food & beverage: $3,754Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $879 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 20 | $467 |
| Janssen Biotech, Inc. | 14 | $430 |
| Lilly USA, LLC | 13 | $356 |
| QOL Medical, LLC | 7 | $226 |
| Ardelyx, Inc. | 7 | $205 |
| Regeneron Healthcare Solutions, Inc. | 7 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $176 |
| Gilead Sciences, Inc. | 8 | $160 |
| Celltrion USA Inc. | 15 | $145 |
Products named: XIFAXAN, TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, OMVOH, Sucraid, IBSRELA.
Industry payments across OH — which companies pay providers there.
